ENDO PHARMA LLC 4

Accession 0001209191-05-052614

CIK 0001100962other

View on SEC.gov Company Profile

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 7:58 PM ET

Size

40.9 KB

Accession

0001209191-05-052614

Insider Transaction Report

Form 4

Period: 2005-10-14

ENDO PHARMACEUTICALS HOLDINGS INCENDP

ENDO PHARMA LLC

10% Owner

Transactions

Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-14$2.42/sh−9,398$22,743→ 22,348,953 total
Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-14$2.42/sh−994$2,405→ 22,360,057 total
Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-14$3.00/sh−358$1,074→ 22,315,265 total
Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-14$3.42/sh−4,580$15,664→ 22,286,590 total
Exercise of In-Money
Call Option (obligation to sell)
2005-10-14$2.42/sh−994$2,405→ 1,371,416 total
Exercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (994 underlying)
Exercise of In-Money
Call Option (obligation to sell)
2005-10-14$2.42/sh−9,398$22,743→ 345,718 total
Exercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (9,398 underlying)
Exercise of In-Money
Call Option (obligation to sell)
2005-10-14$3.00/sh−358$1,074→ 122,086 total
Exercise: $3.00From: 2005-10-13Exp: 2007-08-26→ Common Stock (358 underlying)
Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-14$2.42/sh−1,706$4,129→ 22,358,351 total
Exercise of In-Money
Call Option (obligation to sell)
2005-10-14$2.42/sh−1,706$4,129→ 1,549,129 total
Exercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (1,706 underlying)
Exercise of In-Money
Call Option (obligation to sell)
2005-10-14$2.42/sh−2,958$7,158→ 215,112 total
Exercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (2,958 underlying)
Exercise of In-Money
Call Option (obligation to sell)
2005-10-14$2.42/sh−1,150$2,783→ 141,171 total
Exercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (1,150 underlying)
Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-14$3.00/sh−24,095$72,285→ 22,291,170 total
Exercise of In-Money
Call Option (obligation to sell)
2005-10-14$3.00/sh−22,819$68,457→ 533,939 total
Exercise: $3.00From: 2005-10-13Exp: 2007-08-26→ Common Stock (22,819 underlying)
Exercise of In-Money
Call Option (obligation to sell)
2005-10-14$3.42/sh−4,580$15,664→ 96,839 total
Exercise: $3.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (4,580 underlying)
Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-14$3.00/sh−22,819$68,457→ 22,315,623 total
Exercise of In-Money
Call Option (obligation to sell)
2005-10-14$2.42/sh−6,403$15,495→ 406,388 total
Exercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (6,403 underlying)
Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-14$2.42/sh−2,958$7,158→ 22,345,995 total
Exercise of In-Money
Call Option (obligation to sell)
2005-10-14$3.00/sh−24,095$72,285→ 316,378 total
Exercise: $3.00From: 2005-10-13Exp: 2007-08-26→ Common Stock (24,095 underlying)
Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-14$2.42/sh−6,403$15,495→ 22,339,592 total
Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-14$2.42/sh−1,150$2,783→ 22,338,442 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ENDO PHARMACEUTICALS HOLDINGS INC

CIK 0001100962

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001120075

Filing Metadata

Form type: 4
Filed: Oct 16, 8:00 PM ET
Accepted: Oct 17, 7:58 PM ET
Size: 40.9 KB

View on SEC.gov